{"id":32717,"date":"2013-01-31T20:05:44","date_gmt":"2013-02-01T01:05:44","guid":{"rendered":"http:\/\/countingpips.com\/?p=32717"},"modified":"2013-01-31T20:05:44","modified_gmt":"2013-02-01T01:05:44","slug":"video-kalobios-pharmaceuticals-announces-pricing-of-ipo","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/fx\/2013\/01\/31\/video-kalobios-pharmaceuticals-announces-pricing-of-ipo\/","title":{"rendered":"VIDEO: KaloBios Pharmaceuticals Announces Pricing of IPO"},"content":{"rendered":"<p><div id=\"grabDiv1767162\"><script language=\"javascript\" type=\"text\/javascript\" src=\"http:\/\/player.grabnetworks.com\/js\/Player.js?id=1767162&#038;content=v85849df20ada3d1056241056d141eb0872877831&#038;width=542&#038;height=304&#038;tgt=grabnetworks\"><\/script><\/p>\n<div id=\"overlay-adzone\" style=\"overflow:hidden; position:relative\"><\/div>\n<\/div>\n<p>KaloBios Pharmaceuticals (KBIO) announced the pricing of its previously announced IPO of 8,750,000 shares of common stock at a price to the public of $8.00 per share, less underwriting discounts and commissions. KaloBios has granted the underwriters a 30-day option to purchase up to 1,312,500 additional shares of common stock at the same price to cover over-allotments, if any.<\/p>\n<p><img src='http:\/\/images.grab-media.com\/market_news\/2013\/01\/31\/ID201301IPO013113_thumb.jpg' \/><\/p>\n<p><!--post_img[http:\/\/images.grab-media.com\/market_news\/2013\/01\/31\/ID201301IPO013113_preview.jpg]--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>KaloBios Pharmaceuticals (KBIO) announced the pricing of its previously announced IPO of 8,750,000 shares of common stock at a price to the public of $8.00 per share, less underwriting discounts and commissions. KaloBios has granted the underwriters a 30-day option to purchase up to 1,312,500 additional shares of common stock at the same price to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.investmacro.com\/fx\/2013\/01\/31\/video-kalobios-pharmaceuticals-announces-pricing-of-ipo\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;VIDEO: KaloBios Pharmaceuticals Announces Pricing of IPO&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-32717","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/32717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/comments?post=32717"}],"version-history":[{"count":0,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/32717\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/media?parent=32717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/categories?post=32717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/tags?post=32717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}